Dramatic reductions in hepatic steatosis accompanied by improved HbA1c following a 4-week treatment of obese/diabetic/NAFLD patients with DD01, a novel long-acting GLP-1/glucagon receptor agonist
Bell, Adam, To, Dennis, Karanth, Subbu, Sosnovtseva, Svetlana, Lin, Yen-Huei, Shin, Jaehee
Published in Journal of hepatology (01.06.2023)
Published in Journal of hepatology (01.06.2023)
Get full text
Journal Article
LBP-05 - Dramatic reductions in hepatic steatosis accompanied by improved HbA1c following a 4-week treatment of obese/diabetic/NAFLD patients with DD01, a novel long-acting GLP-1/glucagon receptor agonist
Bell, Adam, To, Dennis, Karanth, Subbu, Sosnovtseva, Svetlana, Lin, Yen-Huei, Shin, Jaehee
Published in Journal of hepatology (01.06.2023)
Published in Journal of hepatology (01.06.2023)
Get full text
Journal Article
72-LB: DD01, a Novel Once-Weekly Dual GLP-1/Glucagon Receptor Agonist, Improves Metabolic Health and Achieves Rapid, Clinically Significant Reductions in Hepatic Steatosis following Only Four Weeks of Treatment and without the Need for Significant Weight Loss in Overweight/Diabetic Subjects with NAFLD
TO, DENNIS, SHIN, JAEHEE, KARANTH, SUBBU, LIN, YEN-HUEI, SOSNOVTSEVA, SVETLANA, BELL, ADAM C.
Published in Diabetes (New York, N.Y.) (20.06.2023)
Published in Diabetes (New York, N.Y.) (20.06.2023)
Get full text
Journal Article